ALXN - Alexion Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue3,551,1003,084,1002,604,000
Cost of Revenue454,200258,300233,100
Gross Profit3,096,9002,825,8002,370,900
Operating Expenses
Research Development878,400757,200709,500
Selling General and Administrative1,135,400988,700926,800
Non Recurring135,60090,30081,300
Others320,100322,200116,600
Total Operating Expenses2,469,5002,158,4001,834,200
Operating Income or Loss627,400667,400536,700
Income from Continuing Operations
Total Other Income/Expenses Net18,8005,7009,200
Earnings Before Interest and Taxes646,200673,100545,900
Interest Expense98,40096,90047,800
Income Before Tax547,800576,200498,100
Income Tax Expense104,500176,800353,700
Minority Interest---
Net Income From Continuing Ops443,300399,400144,400
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income443,300399,400144,400
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares443,300399,400144,400